Skip to main content
. 2018 May 14;24(7):1503–1509. doi: 10.1093/ibd/izy119

Table 2:

Table of Validation Cohort

Summary Median Age Range Age Number of Samples Male:Female Pan:Left:Proc (U) Dur Med
Control 44 24–68 6 5:1 NA NA
Low Risk (Acute) 40 20–66 17 6:11 2:6:9 3
Intermediate (Chronic) 45 21–73 23 10:13 14:3:6 17
Field mucosa 57 38–78 19 15:4 11:2:1 (3) 11
UC-Dys 63.5 43–73 10 6:4 5:1:2 (2) 10
UC-Can 54 26–67 16 14:2 12:0:2 (2) 10
HHS Vulnerability Disclosure